European Journal of Clinical Microbiology

, Volume 6, Issue 4, pp 446–450 | Cite as

Clinical consequences of development of resistance to third generation cephalosporins

  • F. Follath
  • E. Costa
  • A. Thommen
  • R. Frei
  • A. Burdeska
  • J. Meyer
Articles Current Topic Inducible Beta-Lactamases: Enzymes of Increasing Clinical Importance


Eighteen patients are described in whom initially sensitive microorganisms were replaced by resistant isolates during administration of ceftriaxone (n=8), cefoperazone (n=5), moxalactam (n=4), cefotaxime (n=2) or ceftazidime (n=1), despite combination with aminoglycosides. All patients had documented gram-negative infections; in 12 patients underlying haemaotological diseases were present. Resistant strains ofEnterobacter cloacae (14),Serratia marcescens (4),Klebsiella oxytoca (3),Pseudomonas aeruginosa (2) andCitrobacter freundii (2) emerged within 2 to 19 (mean 9) days after the beginning of treatment. In 12 patients relapse or secondary infections occurred. Seven of the patients with haematological disorders died. Resistance development was seen in 8 of 29 patients on ceftriaxone and 4 of 10 patients on moxalactam during prospective evaluations; the other drugs were used sporadically. Thus, selection of resistant bacteria is relatively frequent and may have serious clinical consequences in patients with impaired host-defense mechanisms.


Pseudomonas Aeruginosa Cephalosporin Ceftriaxone Cefotaxime Aminoglycosides 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Franke, E. L., Neu, H. C.: Use of cefotaxime, aβ-lactamase stable cephalosporin, in the therapy of serious infections, including those due to multiresistant organisms. American Journal of Medicine 1981, 71: 435–442.PubMedGoogle Scholar
  2. 2.
    Bailey, R. R., Peddie, B., Blake, E., Bishop, V., Reddy, J.: Cefoperazone in the treatment of severe or complicated infections. Drugs 1981, 22, Supplement: 76–86.PubMedGoogle Scholar
  3. 3.
    Winston, D. J., Busuttil, R. W., Kurtz, T. O., Young, L. S.: Moxalactam therapy for bacterial infections. Archives of Internal Medicine 1981, 141: 1607–1612.PubMedGoogle Scholar
  4. 4.
    Richards, D. M., Heel, R. C., Brogden, R. N., Speight, T. M., Avery, G. S.: Ceftriaxone: a review of its antibacterial activity, pharmacological properties and therapeutic use. Drugs 1984, 27: 469–527.PubMedGoogle Scholar
  5. 5.
    Francioli, P., Clément, M., Geroulanos, S., Von Gtaevenitz, A., Lüthy, R., Régamey, C., Stalder, H., Vogt, M., Waldvogel, F. A.: Ceftazidime in severe infections: a Swiss multicentre study. Journal of Antimicrobial Chemotherapy 1983, 12, Supplement A: 139–146.PubMedGoogle Scholar
  6. 6.
    Then, R. L., Angehrn, P.: Trapping of nonhydrolyzable cephalosporins by cephalosporinases inEnterobacter cloacae andPseudomonas aeruginosa as a possible resistance mechanism. Antimicrobial Agents and Chemotherapy 1982, 21: 711–717.PubMedGoogle Scholar
  7. 7.
    Sanders, C. C., Sanders, W. E.: Emergence of resistance during therapy with the newerβ-lactam antibiotics: role of inducibleβ-lactamases and implications to the future. Reviews of Infectious Diseases 1983, 5: 639–648.PubMedGoogle Scholar
  8. 8.
    Seeberg, A. H., Tolxdorff-Neutzling, R. M., Wiedemann, B.: Chromosomalβ-lactamases ofEnterobacter cloacae are responsible for resistance to third-generation cephalosporins. Antimicrobial Agents and Chemotherapy 1983, 23: 918–925.PubMedGoogle Scholar
  9. 9.
    Prehem, L. C., Penn, R. G., Sanders, C. C., Goering, R. V., Giger, K.: Emergence of resistance toβ-lactam and aminoglycoside antibiotics during moxalactam therapy ofPseudomonas aeruginosa infections. Antimicrobial Agents and Chemotherapy 1982, 22: 1037–1041.PubMedGoogle Scholar
  10. 10.
    Mathisen, G. E., Meyer, F. D., Thompson, J. M., Finegold, S. M.: Clinical evaluation of moxalactam. Antimicrobial Agents and Chemotherapy 1982, 21: 780–786.PubMedGoogle Scholar
  11. 11.
    Blaser, J., Bauernfeind, A., Vogt, M., Lüthy, R.: Monotherapie von systemischenPseudomonas aeruginosa Infektionen mit Ceftazidim. Deutsche Medizinische Wochenschrift 1983, 108: 1312–1317.PubMedGoogle Scholar
  12. 12.
    Bryan, C. S., John, J. F., Sharada Pai, M., Austin, T. L.: Gentamicin vs. cefotaxime for therapy of neonatal sepsis. American Journal of Diseases of Children 1985, 139: 1086–1089.PubMedGoogle Scholar
  13. 13.
    Guggenbichler, J. P., Kofler, J.: Influence of third-generation cephalosporins on aerobic intestinal flora. Journal of Antimicrobial Chemotherapy 1984, 14, Supplement B: 67–70.Google Scholar
  14. 14.
    Sanders, C. C.: Failure to detect resistance in antimicrobial susceptibility tests. A “very major” error of increasing concern. Antimicrobic Newsletter 1984, 1: 27–34.Google Scholar
  15. 15.
    Bush, K., Tanaka, S. K., Bonner, D. P., Sykes, R. B.: Resistance caused by decreased penetration ofβ-lactam antibiotics intoEnterobacter cloacae. Antimicrobial Agents and Chemotherapy 1985, 27: 555–560.PubMedGoogle Scholar
  16. 16.
    DiPiro, J. T., Bowden, T. A., Hooks, V. H.: Prophylactic parenteral cephalosporins in surgery. Are the new agents better? Journal of the American Medical Association 1984, 252: 3277–3279.PubMedGoogle Scholar
  17. 17.
    Nichols, L., Maki, D. G.: The emergence of resistance toβ-lactam antibiotics during treatment ofPseudomonas aeruginosa lower respiratory tract infections: is combination therapy the solution? Chemioterapia 1985, 4: 102–109.PubMedGoogle Scholar
  18. 18.
    Kunin, C. M.: Evaluation of antibiotic usage: a comprehensive look at alternative approaches. Reviews of Infectious Diseases 1981, 3: 745–753.PubMedGoogle Scholar

Copyright information

© Friedr. Vieweg & Sohn Verlagsgesellschaft mbH 1987

Authors and Affiliations

  • F. Follath
    • 1
  • E. Costa
    • 1
  • A. Thommen
    • 1
  • R. Frei
    • 1
  • A. Burdeska
    • 2
  • J. Meyer
    • 2
  1. 1.Department of MedicineUniversity Hospital (Kantonspital)BaselSwitzerland
  2. 2.Department of Microbiology, BiozentrumUniversity of BaselSwitzerland

Personalised recommendations